ArticleLasers in medical science2026
Laser photobiomodulation enhances cell viability and regenerative gene expression in oxidative-stressed muscle cells.
Article in Lasers in medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to evaluate the effects of laser photobiomodulation therapy (LPT) on muscle cells subjected to oxidative stress. The primary objective was to determine whether LPT could preserve cell viability and modulate the expression of genes associated with muscle regeneration, specifically MyoD and myogenin, as well as the pro-inflammatory cytokine IL-6. Methods: C2C12 myoblasts were cultured and exposed to oxidative stress using hydrogen peroxide (H₂O₂) at a concentration of 50 µM for 1 h. Cells were then irradiated with LPT at wavelengths of 660–808 nm with fluences of 3, 5, and 10 J, applied either before (PRE-OS) or after (POST-OS) oxidative stress induction. Cell viability was assessed by the MTT assay, and gene expression was quantified using RT-qPCR. Results: Oxidative stress significantly reduced cell viability. LPT applied prior to OS with 660 nm (3 J) and 808 nm (3 and 10 J) attenuated this reduction. Notably, 10 J at 808 nm (PRE-OS) increased viability beyond control levels and markedly upregulated MyoD expression. Myogenin expression was also observed under 10 J PRE-OS conditions, while IL-6 expression was detected with 5 J at both wavelengths in PRE- and POST-OS groups. Conclusion: LPT demonstrated protective and regenerative effects on myoblasts under oxidative stress, preserving viability and enhancing regenerative gene expression. These findings support the potential of LPT as a therapeutic strategy for muscle injuries and disorders associated with oxidative stress.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.